UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 13, 2026
Sale
Calculated transaction value
$21.36K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 12, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$511.72
Aug 12, 2026
Close before public filing
$511.72
Aug 12, 2026
Return since public filing
-2.86%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 41 shares @ $520.96
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000119
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.18M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 12, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $20.28K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $223.9K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $142.69K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $588.81K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $277.37K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $618.7K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $286.91K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $459.78K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $646K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $165.81K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $602.61K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $353.34K |
| United Therapeutics Corp UTHR Current | Sale | Aug 12, 2026 | $21.36K |
| United Therapeutics Corp UTHR | Sale | Aug 12, 2026 | $485.19K |